Resources from the same session
1522MO - Hormonal contraception and pregnancy and risk of progression or relapse in desmoid-type fibromatosis (DF)
Presenter: Marion DEBAUDRINGHIEN
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
1523MO - Initial active surveillance strategy for patients with peripheral sporadic desmoids: A multicentre phase II observational trial
Presenter: Sylvie Bonvalot
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
1524MO - Patterns of care and outcomes of 64 CIC-rearranged sarcoma: A retrospective multicentre case-series within the French Sarcoma Group (FSG)
Presenter: Brahmi Mehdi
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
1525MO - Phase I/II study of MAK683 in patients (pts) with advanced malignancies including epithelioid sarcoma
Presenter: Rastislav Bahleda
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
1526MO - GEMMK: A phase I study of gemcitabine (gem) and pembrolizumab (pem) in patients (pts) with leiomyosarcoma (LMS) and undifferentiated pleomorphic sarcoma UPS)
Presenter: Alannah Smrke
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
1527MO - Biomarkers of response and hyperprogression in patients with sarcoma treated with checkpoint blockade
Presenter: Nicholas Klemen
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
Discussion 1524MO and 1525MO
Presenter: Anna Maria Frezza
Session: Mini oral session - Sarcoma
Resources:
Slides
Webcast
Discussion 1526MO and 1527MO
Presenter: Olivier Mir
Session: Mini oral session - Sarcoma
Resources:
Slides
Webcast